This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
OT-82, a novel anticancer drug candidate that targets the strong dependence of hematological malignancies on NAD biosynthesis
Leukemia Open Access 02 January 2020
-
Upregulation of mitochondrial NAD+ levels impairs the clonogenicity of SSEA1+ glioblastoma tumor-initiating cells
Experimental & Molecular Medicine Open Access 09 June 2017
-
Sirtuins in metabolism, DNA repair and cancer
Journal of Experimental & Clinical Cancer Research Open Access 05 December 2016
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Berger, F., Ramirez-Hernandez, M.H. & Ziegler, M. Trends Biochem. Sci. 29, 111–118 (2004).
Lanska, D.J. Ann. Nutr. Metab. 61, 246–253 (2012).
Mouchiroud, L. et al. Cell 154, 430–441 (2013).
Cantó, C. et al. Cell Metab. 15, 838–847 (2012).
Yoshino, J. et al. Cell Metab. 14, 528–536 (2011).
He, W. et al. Trends Endocrinol. Metab. 23, 467–476 (2012).
Tissenbaum, H.A. & Guarente, L. Nature 410, 227–230 (2001).
Rogina, B., Helfand, S.L. & Frankel, S. Science 298, 1745 (2002).
Imai, S. et al. Nature 403, 795–800 (2000).
Lin, S.J., Defossez, P.A. & Guarente, L. Science 289, 2126–2128 (2000).
Burnett, C. et al. Nature 477, 482–485 (2011).
Banerjee, K.K. et al. Cell Rep. 2, 1485–1491 (2012).
Sinclair, D. & Verdin, E. Cell Rep. 2, 1473–1474 (2012).
Cohen, H.Y. et al. Science 305, 390–392 (2004).
Kanfi, Y. et al. Nature 483, 218–221 (2012).
Satoh, A. et al. Cell Metab. 18, 416–430 (2013).
Nakahata, Y. et al. Cell 134, 329–340 (2008).
Gut, P. & Verdin, E. Nature 502, 489–498 (2013).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
E.V. is a member of the scientific advisory board of SIRTRIS/GSK.
Rights and permissions
About this article
Cite this article
Verdin, E. The Many Faces of Sirtuins: Coupling of NAD metabolism, sirtuins and lifespan. Nat Med 20, 25–27 (2014). https://doi.org/10.1038/nm.3447
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.3447
This article is cited by
-
OT-82, a novel anticancer drug candidate that targets the strong dependence of hematological malignancies on NAD biosynthesis
Leukemia (2020)
-
Upregulation of mitochondrial NAD+ levels impairs the clonogenicity of SSEA1+ glioblastoma tumor-initiating cells
Experimental & Molecular Medicine (2017)
-
Mitochondrial elongation-mediated glucose metabolism reprogramming is essential for tumour cell survival during energy stress
Oncogene (2017)
-
Sirtuins in metabolism, DNA repair and cancer
Journal of Experimental & Clinical Cancer Research (2016)
-
Nicotinamide mononucleotide adenylyltransferase promotes hypoxic survival by activating the mitochondrial unfolded protein response
Cell Death & Disease (2016)